Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Cell Biol
2011 Nov 01;3122:4392-404. doi: 10.1128/MCB.05517-11.
Show Gene links
Show Anatomy links
Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activity.
Luz S
,
Kongsuphol P
,
Mendes AI
,
Romeiras F
,
Sousa M
,
Schreiber R
,
Matos P
,
Jordan P
,
Mehta A
,
Amaral MD
,
Kunzelmann K
,
Farinha CM
.
???displayArticle.abstract???
Previously, the pleiotropic "master kinase" casein kinase 2 (CK2) was shown to interact with CFTR, the protein responsible for cystic fibrosis (CF). Moreover, CK2 inhibition abolished CFTR conductance in cell-attached membrane patches, native epithelial ducts, and Xenopus oocytes. CFTR possesses two CK2 phosphorylation sites (S422 and T1471), with unclear impact on its processing and trafficking. Here, we investigated the effects of mutating these CK2 sites on CFTR abundance, maturation, and degradation coupled to effects on ion channel activity and surface expression. We report that CK2 inhibition significantly decreased processing of wild-type (wt) CFTR, with no effect on F508del CFTR. Eliminating phosphorylation at S422 and T1471 revealed antagonistic roles in CFTR trafficking: S422 activation versus T1471 inhibition, as evidenced by a severe trafficking defect for the T1471D mutant. Notably, mutation of Y512, a consensus sequence for the spleen tyrosine kinase (SYK) possibly acting in a CK2 context adjacent to the common CF-causing defect F508del, had a strong effect on both maturation and CFTR currents, allowing the identification of this kinase as a novel regulator of CFTR. These results reinforce the importance of CK2 and the S422 and T1471 residues for regulation of CFTR and uncover a novel regulation of CFTR by SYK, a recognized controller of inflammation.
Barro-Soria,
Bestrophin 1 and 2 are components of the Ca(2+) activated Cl(-) conductance in mouse airways.
2008, Pubmed
Barro-Soria,
Bestrophin 1 and 2 are components of the Ca(2+) activated Cl(-) conductance in mouse airways.
2008,
Pubmed
Blom,
Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence.
2004,
Pubmed
Briel,
Cl- transport by cystic fibrosis transmembrane conductance regulator (CFTR) contributes to the inhibition of epithelial Na+ channels (ENaCs) in Xenopus oocytes co-expressing CFTR and ENaC.
1998,
Pubmed
,
Xenbase
Chang,
Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites.
1993,
Pubmed
Collins,
Cystic fibrosis: molecular biology and therapeutic implications.
1992,
Pubmed
Cozza,
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
2009,
Pubmed
Csanády,
Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
2005,
Pubmed
,
Xenbase
Faria,
Effect of Annexin A5 on CFTR: regulated traffic or scaffolding?
2011,
Pubmed
,
Xenbase
Farinha,
The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70.
2002,
Pubmed
Farinha,
Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin.
2005,
Pubmed
Gentzsch,
Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator.
2004,
Pubmed
Gil,
Protein kinase CK2 associates to lipid rafts and its pharmacological inhibition enhances neurotransmitter release.
2011,
Pubmed
Greenberg,
Modular components of phagocytosis.
1999,
Pubmed
Guggino,
New insights into cystic fibrosis: molecular switches that regulate CFTR.
2006,
Pubmed
Jensen,
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.
1995,
Pubmed
Kanelis,
NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR.
2010,
Pubmed
Lu,
Co- and posttranslational translocation mechanisms direct cystic fibrosis transmembrane conductance regulator N terminus transmembrane assembly.
1998,
Pubmed
Meacham,
The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis.
1999,
Pubmed
Meggio,
One-thousand-and-one substrates of protein kinase CK2?
2003,
Pubmed
Mehta,
The cystic fibrosis transmembrane recruiter the alter ego of CFTR as a multi-kinase anchor.
2007,
Pubmed
Mendes,
Antagonistic regulation of cystic fibrosis transmembrane conductance regulator cell surface expression by protein kinases WNK4 and spleen tyrosine kinase.
2011,
Pubmed
Mense,
In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer.
2006,
Pubmed
,
Xenbase
Mócsai,
The SYK tyrosine kinase: a crucial player in diverse biological functions.
2010,
Pubmed
Navara,
The spleen tyrosine kinase (Syk) in human disease, implications for design of tyrosine kinase inhibitor based therapy.
2004,
Pubmed
Pagano,
Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis.
2008,
Pubmed
Pagano,
Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2.
2010,
Pubmed
Peters,
Role of snare proteins in CFTR and ENaC trafficking.
2001,
Pubmed
Pissarra,
Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation.
2008,
Pubmed
Riccaboni,
Spleen tyrosine kinases: biology, therapeutic targets and drugs.
2010,
Pubmed
Riordan,
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
1989,
Pubmed
Roxo-Rosa,
Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
2006,
Pubmed
Sanderson,
Syk: a novel target for treatment of inflammation in lung disease.
2009,
Pubmed
Sarker,
Casein kinase 2 binds to the C terminus of Na+/H+ exchanger 3 (NHE3) and stimulates NHE3 basal activity by phosphorylating a separate site in NHE3.
2008,
Pubmed
Schultz,
Pharmacology of CFTR chloride channel activity.
1999,
Pubmed
Scott-Ward,
Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone.
2009,
Pubmed
Tabcharani,
Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene.
1991,
Pubmed
Takahashi,
CFTR-dependent membrane insertion is linked to stimulation of the CFTR chloride conductance.
1996,
Pubmed
,
Xenbase
Treharne,
Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR.
2009,
Pubmed
,
Xenbase
Ulanova,
Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells.
2005,
Pubmed
Weber,
Functional integrity of the vesicle transporting machinery is required for complete activation of cFTR expressed in xenopus laevis oocytes.
2001,
Pubmed
,
Xenbase
Winter,
Stimulation of CFTR activity by its phosphorylated R domain.
1997,
Pubmed
